# TCIRG1

## Overview
The TCIRG1 gene encodes the T cell immune regulator 1, ATPase H+ transporting V0 subunit a3, a critical component of the vacuolar H+-ATPase (V-ATPase) complex. This protein functions as a proton pump, playing a pivotal role in acidifying various intracellular compartments, particularly within osteoclasts, where it is essential for bone resorption. The a3 subunit is a transmembrane protein that facilitates the transport of hydrogen ions across membranes, contributing to the acidification necessary for dissolving bone mineral and degrading the bone matrix. Mutations in the TCIRG1 gene are linked to autosomal recessive osteopetrosis, a condition characterized by increased bone density due to impaired osteoclast function (Susani2004TCIRG1dependent; Frattini2000Defects). The gene's expression and function are crucial for maintaining bone homeostasis and are also implicated in immune regulation, highlighting its broader physiological significance (Di2023Glycolysisrelated).

## Structure
The TCIRG1 gene encodes the a3 subunit of the vacuolar H+-ATPase (V-ATPase) complex, which functions as a proton pump across membranes (Shinwari2022Novel). The protein is 830 amino acids long with a molecular mass of 92,968 Da and contains three domains, including the V-TYPE PROTON ATPASE 116 KDA SUBUNIT A ISOFORM 3, and both cytoplasmic and non-cytoplasmic regions (Shinwari2022Novel). The V-ATPase complex consists of a cytoplasmic V1 domain responsible for ATP hydrolysis and a membrane-embedded V0 domain that functions as a proton translocator (Anderson2014A). The a3 isoform is highly enriched in osteoclasts and is crucial for bone resorption by acidifying the resorption lacunae (Zirngibl2019Novel).

Post-translational modifications such as phosphorylation and glycosylation are predicted to occur in the TCIRG1 protein, influencing its function and stability (Shinwari2022Novel). The protein's structure is further characterized by its involvement in the V-ATPase complex, where it plays a critical role in proton translocation and subunit interactions (Zirngibl2019Novel). The TCIRG1 gene also has splice variant isoforms, with the a3 isoform being specific to osteoclasts (ElKamah2023Outlining).

## Function
The TCIRG1 gene encodes the a3 subunit of the vacuolar proton pump (V-ATPase), which is crucial for the acidification of the bone/osteoclast interface. This acidification is essential for normal bone metabolism, as it allows osteoclasts to dissolve bone mineral and degrade the bone matrix, facilitating bone resorption and remodeling (Susani2004TCIRG1dependent; Frattini2000Defects). The TCIRG1 protein is specifically expressed in osteoclasts and is localized at the ruffled border membrane, where it mediates the transport of hydrogen ions (H+) into the resorption lacunae, creating a low pH environment necessary for dissolving hydroxyapatite crystals in bone (Frattini2000Defects).

In healthy human cells, the proper functioning of the TCIRG1 gene ensures the maintenance of bone density and structure by enabling osteoclasts to perform their resorptive functions effectively (Susani2004TCIRG1dependent). The gene's role in osteoclast function is underscored by its involvement in calcium signaling pathways, which are crucial for osteoclastogenesis and the regulation of osteoclast size and activity (Zhang2020Knockdown). Dysfunction of TCIRG1 leads to impaired bone resorption, resulting in conditions such as autosomal recessive osteopetrosis (Susani2004TCIRG1dependent; Frattini2000Defects).

## Clinical Significance
Mutations in the TCIRG1 gene are primarily associated with autosomal recessive osteopetrosis (ARO), a severe genetic disorder characterized by increased bone density due to defective osteoclast function. This condition often results in symptoms such as abnormal bone structure, fractures, absence of a bone marrow cavity, anemia, and thrombocytopenia. ARO is frequently fatal within the first years of life (Anderson2014A). The TCIRG1 gene encodes the a3 subunit of the vacuolar proton pump, which is crucial for the acidification process necessary for bone resorption. Mutations in this gene disrupt the function of the vacuolar proton pump, leading to osteoclast dysfunction and inadequate bone resorption (Scimeca2003Novel; Frattini2000Defects).

Specific mutations, such as the c.117+4A→T mutation, have been identified in certain populations, including the Ashkenazi Jewish population, where it is considered a founder mutation (Anderson2014A). Other mutations, like c.G630A, result in milder forms of ARO due to residual expression of functional protein (Zirngibl2019Novel). Additionally, TCIRG1 mutations have been linked to severe congenital neutropenia, a hematological disorder characterized by low neutrophil counts and recurrent infections (Shinwari2022Novel).

## Interactions
The TCIRG1 gene encodes a protein that is a component of the vacuolar H+-ATPase (V-ATPase) complex, which is crucial for proton transport and acidification of intracellular compartments. This protein interacts with other subunits of the V-ATPase complex, such as ATP6V1 and ATP6V0, to facilitate its function in osteoclasts and other cells (Zhang2020Knockdown). In osteoclasts, TCIRG1 is involved in the formation of the ruffled border membrane, where it plays a role in bone resorption by creating an acidic environment necessary for this process (Frattini2000Defects).

TCIRG1 also interacts with proteins involved in calcium signaling pathways, such as NFATc1 and IP3R2. Knockdown studies have shown that reducing TCIRG1 expression leads to decreased NFATc1 expression and its nuclear translocation, as well as reduced IP3R2 expression, which affects intracellular calcium levels. These interactions are important for osteoclastogenesis and the generation of large osteoclasts (Zhang2020Knockdown).

In the context of cancer, TCIRG1 expression is associated with immune cell infiltration and immune checkpoint molecules, suggesting its involvement in immune regulation and potential interactions with immune-related proteins (Di2023Glycolysisrelated).


## References


[1. (Anderson2014A) S.L. Anderson, C. Jalas, A. Fedick, K.F. Reid, T.O. Carpenter, D. Chirnomas, N.R. Treff, J. Ekstein, and B.Y. Rubin. A founder mutation in the <scp>tcirg1</scp> gene causes osteopetrosis in the ashkenazi jewish population. Clinical Genetics, 88(1):74–79, July 2014. URL: http://dx.doi.org/10.1111/cge.12448, doi:10.1111/cge.12448. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/cge.12448)

[2. (Scimeca2003Novel) Jean-Claude Scimeca, Danielle Quincey, Hugues Parrinello, Delphine Romatet, Josiane Grosgeorge, Patrick Gaudray, Nicole Philip, Alain Fischer, and Georges F. Carle. Novel mutations in thetcirg1gene encoding the a3 subunit of the vacuolar proton pump in patients affected by infantile malignant osteopetrosis. Human Mutation, 21(2):151–157, February 2003. URL: http://dx.doi.org/10.1002/humu.10165, doi:10.1002/humu.10165. This article has 39 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.10165)

[3. (Zirngibl2019Novel) Ralph A. Zirngibl, Andrew Wang, Yeqi Yao, Morris F. Manolson, Joerg Krueger, Lucie Dupuis, Roberto Mendoza‐Londono, and Irina Voronov. Novel c.g630a tcirg1 mutation causes aberrant splicing resulting in an unusually mild form of autosomal recessive osteopetrosis. Journal of Cellular Biochemistry, 120(10):17180–17193, May 2019. URL: http://dx.doi.org/10.1002/jcb.28979, doi:10.1002/jcb.28979. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcb.28979)

[4. (Frattini2000Defects) Annalisa Frattini, Paul J. Orchard, Cristina Sobacchi, Silvia Giliani, Mario Abinun, Jan P. Mattsson, David J. Keeling, Ann-Katrin Andersson, Pia Wallbrandt, Luigi Zecca, Luigi D. Notarangelo, Paolo Vezzoni, and Anna Villa. Defects in tcirg1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nature Genetics, 25(3):343–346, July 2000. URL: http://dx.doi.org/10.1038/77131, doi:10.1038/77131. This article has 533 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/77131)

[5. (Di2023Glycolysisrelated) Sichen Di, Min Gong, Jianmin Lv, Qiwei Yang, Ye Sun, Yijun Tian, Cheng Qian, Wenjin Chen, Wang Zhou, Keqin Dong, Xiaokai Shi, Yuning Wang, Hongru Wang, Jian Chu, Sishun Gan, Xiuwu Pan, and Xingang Cui. Glycolysis-related biomarker tcirg1 participates in regulation of renal cell carcinoma progression and tumor immune microenvironment by affecting aerobic glycolysis and akt/mtor signaling pathway. Cancer Cell International, August 2023. URL: http://dx.doi.org/10.1186/s12935-023-03019-0, doi:10.1186/s12935-023-03019-0. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12935-023-03019-0)

[6. (Susani2004TCIRG1dependent) Lucia Susani, Alessandra Pangrazio, Cristina Sobacchi, Anna Taranta, Geert Mortier, Ravi Savarirayan, Anna Villa, Paul Orchard, Paolo Vezzoni, Alberto Albertini, Annalisa Frattini, and Franco Pagani. Tcirg1-dependent recessive osteopetrosis: mutation analysis, functional identification of the splicing defects, andin vitro rescue by u1 snrna. Human Mutation, 24(3):225–235, 2004. URL: http://dx.doi.org/10.1002/humu.20076, doi:10.1002/humu.20076. This article has 77 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.20076)

[7. (Zhang2020Knockdown) Dongyan Zhang, Liying Lin, Bingwu Yang, Zhen Meng, and Bin Zhang. Knockdown of tcirg1 inhibits large-osteoclast generation by down-regulating nfatc1 and ip3r2 expression. PLOS ONE, 15(8):e0237354, August 2020. URL: http://dx.doi.org/10.1371/journal.pone.0237354, doi:10.1371/journal.pone.0237354. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0237354)

[8. (Shinwari2022Novel) Khyber Shinwari, Hafiz Muzzammel Rehman, Guojun Liu, Mikhail A. Bolkov, Irina A. Tuzankina, and Valery. A. Chereshnev. Novel disease-associated missense single-nucleotide polymorphisms variants predication by algorithms tools and molecular dynamics simulation of human tcirg1 gene causing congenital neutropenia and osteopetrosis. Frontiers in Molecular Biosciences, April 2022. URL: http://dx.doi.org/10.3389/fmolb.2022.879875, doi:10.3389/fmolb.2022.879875. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmolb.2022.879875)

[9. (ElKamah2023Outlining) Ghada Y. El-Kamah, Mennat I. Mehrez, Mohamed B. Taher, Hala T. El-Bassyouni, Khaled R. Gaber, and Khalda S. Amr. Outlining the clinical profile of tcirg1 14 variants including 5 novels with overview of aro phenotype and ethnic impact in 20 egyptian families. Genes, 14(4):900, April 2023. URL: http://dx.doi.org/10.3390/genes14040900, doi:10.3390/genes14040900. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes14040900)